Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Am J Kidney Dis. 2022 Aug 6;81(1):59–66. doi: 10.1053/j.ajkd.2022.06.008

Table 1:

Characteristics of participants at baseline:

Study Sample
(N=99)
Exercise (N=49) Health Education
Control (N=50)
p-value
comparing
randomized
groups
Age (years) 68.8 (8.2) 67.9 (7.7) 68.1 (8.8) 0.9
Female 25 (25.3%) 15 (30.6%) 10 (20.0%) 0.2
Race 0.4
 African American 61 (61.6%) 27 (55.1%) 34 (68%)
 Caucasian 31 (31.3%) 18 (36.7%) 13 (26.0%)
 Other 7 (7.1%) 4 (8.1%) 3 (6%)
eGFR (ml/min/1.73m2) 33.3 (10.5) 34.1 (9.5) 32.6 (11.4) 0.5
Hb (g/dL) 12.4 (1.6) 12.5 (1.6) 12.3(1.7) 0.5
BMI (kg/m2) 31.1 (6.5) 30.3 (7.2) 31.8 (5.8) 0.3
Self-reported Moderate-vigorous physical activity (minutes/week) 78 (150) 72 (126) 90 (174) 0.6
CAD 29 (29.3%) 16 (32.7%) 13 (26.0%) 0.5
Diabetes 58 (58.6%) 30 (61.2%) 28 (56.0%) 0.6
Hypertension 92 (92.9%) 44 (89.8%) 48 (96.0%) 0.3
CHF 1 10 (10.1%) 6 (12.2%) 4(8.0%) 0.5
Peripheral vascular disease2 9 (9.1%) 3 (6.1%) 6 (12%)
Smoking 0.5
 Current 16 (16.2%) 10 (20.4%) 6 (12.0%)
 Former 58 (58.6%) 28 (57.1%) 30 (60.0%)
 Never 25 (25.3%) 11 (22.4%) 14 (28.0%)
Stroke or TIA 16 (16.2%) 9 (18.4%) 7 (14.0%)
COPD 13 (13.1%) 5 (10.2%) 8 (16.0%) 0.5
Site
 Tufts 43 (43.4%) 21 (42.9%) 22 (44.0%) 0.9
 Univ of Maryland 56.6%) 28 (57.1%) 28 (56.0%)

CAD: Coronary Artery Disease; CHF: Congestive Heart Failure; COPD: Chronic Obstructive Pulmonary Disease; TIA: Transient Ischemic Attack

1.

Patient with NYHA Class III-IV symptoms were excluded.

2.

Patients with symptomatic claudication were excluded.

3.

Patients with disabling stroke were excluded.